HOME»Activity

Activity

2019

2019-2 EQA for breast cancer cancer

Category   Proficiency testing using WSI
Evaluation Element   Evaluation of IHC for ER,HER
Implementation Period   29 Nov 2019 (Fri) - 23 Dec 2019 (Mon)

2019-1 IHC for ER and HER2 in breast cancer

Category   Immunohistochemical staining of reference TMA slides
Evaluation Element   Evaluation of IHC for ER and HER2 antibody
Implementation Period   13 Aug 2019 (Tue) - 13 Sep 2019 (Fri)

2018

2018-2 EQA for cancer of unknown primary

Category   Proficiency testing using WSI
Evaluation Element   Cancer of unknown primary
Implementation Period   25 Dec 2018 (Tue) - 25 Jan 2019 (Fri)

2018-1 IHC for chromogranin A and synaptophysin in pulmonary neuroendocrine tumor

Category   Immunohistochemical staining of reference TMA slides
Evaluation Element   Evaluation of IHC for chromogranin A and synaptophysin antibody 
Implementation Period   23 Jul 2018 (Mon) - 24 Aug 2018 (Fri)

2017

2017-2 EQA for lung cancer

Category   Proficiency testing using WSI
Evaluation Element   Evaluation of IHC for Lung cancer
Implementation Period   12 Dec 2017 (Tue) - 28 Dec 2017 (Thu)

2017-1 IHC for TTF-1, p40, and ALK in lung cancer

Category   Immunohistochemical staining of reference TMA slides
Evaluation Element   Evaluation of IHC for TTF-1, p40 and ALK antibody
Implementation Period   25 Jul 2017 (Tue) - 25 Aug 2017 (Fri)

2016

2016-2 EQA for malignant lymphoma

Category   Proficiency testing using WSI
Evaluation Element   Evaluation of IHC for Malignant lymphoma
Implementation Period   23 Jan 2017 (Mon) - 6 Feb 2017 (Mon)

2016-1 IHC for CD30 in malignant lymphoma

Category   Immunohistochemical staining of reference TMA slides
Evaluation Element   Evaluation of IHC for CD30 antibody
Implementation Period   20 Oct 2016 (Thu) - 22 Nov 2016 (Tue)

2015

2015-2 EQA for gastric cancer and gastrointesintla stromal tumor (GIST)

Category   Proficiency testing using WSI
Evaluation Element   Evaluation of IHC for HER2 antibody in gastric cancer and Kit in gastrointestinao stromal tumor (GIST)
Implementation Period   28 Jan 2016 (Thu) - 17 Feb 2016 (Wed)

2015-1 IHC for CD117 in gastrointestinal stromal tumor

Category   Immunohistochemical staining of reference TMA slides
Evaluation Element   Immunohistochemistry for CD117 antibody

2014

2014-1 EQA for breast cancer

Category   Proficiency testing using WSI
Evaluation Element   Evaluation of IHC for ER, PgR and HER2 antibody

Copyright © Japan Pathology Quality Assurance System all rights reserved.